38 related articles for article (PubMed ID: 580366)
1. Safety and efficacy of a feed additive consisting of glyceryl polyethyleneglycol ricinoleate (PEG castor oil) for all animal species (FEFANA asbl).
; Bampidis V; Azimonti G; Bastos ML; Christensen H; Dusemund B; Fašmon Durjava M; Kouba M; López-Alonso M; López Puente S; Marcon F; Mayo B; Pechová A; Petkova M; Ramos F; Sanz Y; Villa RE; Woutersen R; Aquilina G; Bories G; Gropp J; Nebbia C; Innocenti M
EFSA J; 2022 Oct; 20(10):e07433. PubMed ID: 36320457
[TBL] [Abstract][Full Text] [Related]
2. A Call for Systems Epidemiology to Tackle the Complexity of Schistosomiasis, Its Control, and Its Elimination.
Krauth SJ; Balen J; Gobert GN; Lamberton PHL
Trop Med Infect Dis; 2019 Jan; 4(1):. PubMed ID: 30699922
[TBL] [Abstract][Full Text] [Related]
3. A Novel Strategy to Predict Carcinogenicity of Antiparasitics Based on a Combination of DNA Lesions and Bacterial Mutagenicity Tests.
Liu Q; Lei Z; Zhu F; Ihsan A; Wang X; Yuan Z
Front Public Health; 2017; 5():288. PubMed ID: 29170735
[TBL] [Abstract][Full Text] [Related]
4. Mutagenicity testing with transgenic mice. Part I: Comparison with the mouse bone marrow micronucleus test.
Wahnschaffe U; Bitsch A; Kielhorn J; Mangelsdorf I
J Carcinog; 2005 Jan; 4(1):3. PubMed ID: 15655069
[TBL] [Abstract][Full Text] [Related]
5. Promotion of rat hepatocarcinogenesis by praziquantel.
Shirai T; Joong KD; Hakoi K; Thamavit W; Pairojkul C; Hoshiya T; Hasegawa R; Ito N
Jpn J Cancer Res; 1991 Oct; 82(10):1085-8. PubMed ID: 1683346
[TBL] [Abstract][Full Text] [Related]
6. Multicentre trials of praziquantel in human schistosomiasis: design and techniques.
Davis A; Wegner DH
Bull World Health Organ; 1979; 57(5):767-71. PubMed ID: 317254
[TBL] [Abstract][Full Text] [Related]
7. The mutagenicity of saccharin.
Kramers PG
Mutat Res; 1975; 32(1):81-92. PubMed ID: 1095924
[TBL] [Abstract][Full Text] [Related]
8. Mutagenicity studies with praziquantel, a new anthelmintic drug, in mammalian systems.
Machemer L; Lorke D
Arch Toxicol; 1978 Jan; 39(3):187-97. PubMed ID: 580366
[TBL] [Abstract][Full Text] [Related]
9. Nucleus anomaly test and chromosomal analysis of bone marrow cells of the Chinese hamster and dominant lethal test in male mice after treatment with fluorescent whitening agents.
Müller D; Fritz H; Langauer M; Strasser FF
Environ Qual Saf Suppl; 1975; 4():247-63. PubMed ID: 1064545
[TBL] [Abstract][Full Text] [Related]
10. Method for testing mutagenic effects of chemicals on spermatogonia of the Chinese hamster: results obtained with cyclophosphamide, saccharin, and cyclamate.
Machemer L; Lorke D
Arzneimittelforschung; 1975; 25(12):1889-96. PubMed ID: 1243659
[TBL] [Abstract][Full Text] [Related]
11. Absence of povidone-iodine-induced mutagenicity in mice and hamsters.
Merkle J; Zeller H
J Pharm Sci; 1979 Jan; 68(1):100-2. PubMed ID: 758440
[TBL] [Abstract][Full Text] [Related]
12. Comparative studies on the mutagenicity of pirenzepine with submammalian/bacterial and mammalian systems.
Baumeister M
Toxicol Appl Pharmacol; 1980 Jul; 54(3):384-91. PubMed ID: 6994270
[No Abstract] [Full Text] [Related]
13. Absence of mutagenicity of praziquantel, a new, effective, anti-schistosomal drug, in bacteria, yeasts, insects and mammalian cells.
Bartsch H; Kuroki T; Malaveille C; Loprieno N; Barale R; Abbondandolo A; Bonatti S; Rainaldi G; Vogel E; Davis A
Mutat Res; 1978 Nov; 58(2-3):133-42. PubMed ID: 106268
[TBL] [Abstract][Full Text] [Related]
14. [The mutagenic effect of endoxan on the mouse].
Brittinger D
Humangenetik; 1966; 3(2):156-65. PubMed ID: 5984975
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
